89bio Inc (ETNB)
8.26
+0.01
(+0.12%)
USD |
NASDAQ |
Apr 26, 16:00
8.26
0.00 (0.00%)
After-Hours: 20:00
89bio Cash from Operations (Quarterly): -34.29M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -34.29M |
| September 30, 2023 | -30.36M |
| June 30, 2023 | -34.45M |
| March 31, 2023 | -30.08M |
| December 31, 2022 | -27.10M |
| September 30, 2022 | -14.82M |
| June 30, 2022 | -14.84M |
| March 31, 2022 | -24.34M |
| December 31, 2021 | -28.24M |
| September 30, 2021 | -13.45M |
| Date | Value |
|---|---|
| June 30, 2021 | -20.11M |
| March 31, 2021 | -14.98M |
| December 31, 2020 | -14.03M |
| September 30, 2020 | -12.94M |
| June 30, 2020 | -11.52M |
| March 31, 2020 | -7.752M |
| December 31, 2019 | -11.13M |
| September 30, 2019 | -6.197M |
| June 30, 2019 | -3.964M |
| March 31, 2019 | -4.167M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-34.45M
Minimum
Jun 2023
-3.964M
Maximum
Jun 2019
-18.66M
Average
-14.84M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -79.93M |
| Akero Therapeutics Inc | -48.63M |
| Viking Therapeutics Inc | -6.134M |
| Galectin Therapeutics Inc | -4.702M |
| Terns Pharmaceuticals Inc | -19.32M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -63.64M |
| Cash from Financing (Quarterly) | 162.17M |
| Free Cash Flow | -129.19M |
| Free Cash Flow Per Share (Quarterly) | -0.4244 |
| Free Cash Flow Yield | -21.99% |